YOLFTbeta
908 Devices Inc

908 Devices Inc

MASS · NASDAQ · Healthcare / Medical Devices

9.74USD-0.05 (-0.51%)

Price History

Full chart

Market Stats

Previous Close9.79
Open9.77
Day Range9.35 – 10.02
52-Week Range5.03 – 11.72
Volume343.98K
Market Cap472.86M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.93
Dividend Yield0.00%
Beta0.68
50-Day Avg9.42
200-Day Avg7.55

About

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Kevin J. Knopp Ph.D.
  • Employees172
  • Headquarters44 3rd Avenue, Burlington, MA, United States, 01803, USA
  • Websitehttps://908devices.com

Leadership

  • Dr. Kevin J. Knopp Ph.D.Co-Founder, CEO, President & Director · b. 1973
  • Dr. Christopher David Brown Ph.D.Co-Founder, Board Advisor & Director · b. 1975
  • Mr. Joseph H. Griffith IVCFO & Treasurer · b. 1975
  • Mr. Mark S. Levine J.D.Chief Legal, Administrative Officer & Corporate Secretary · b. 1973
  • Mr. John KennewegSenior Vice President of Sales and Product Marketing · b. 1973
  • Ms. Julie CincottiGlobal Head of Human Resources
  • Dr. Kevin McCallion Ph.D.Senior Vice President of Products and Production · b. 1966
  • Mr. Kola OtitojuChief Business & Strategy Officer · b. 1973

Financials

Income Statement

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue22.05M17.97M26.89M42.21M46.85M50.23M59.63M56.20M
Growth (%)--18.51%+49.64%+56.93%+11.01%+7.21%+18.72%-5.76%
Cost of Revenue9.66M9.83M11.97M18.97M20.83M24.91M29.71M29.40M
Gross Profit12.39M8.14M14.92M23.23M26.02M25.32M29.93M26.80M
Gross Margin56.19%45.31%55.49%55.05%55.54%50.41%50.18%47.68%
Operating Expense18.83M20.29M20.74M45.30M61.41M68.08M106.64M50.98M
Operating Income-6.44M-12.14M-5.82M-22.07M-35.38M-42.76M-76.72M-24.18M
Operating Margin-29.20%-67.57%-21.62%-52.29%-75.52%-85.13%-128.65%-43.03%
EBITDA-5.49M-11.24M-4.98M-20.76M-33.77M-40.27M-43.88M-28.88M
EBITDA Margin-24.91%-62.56%-18.53%-49.18%-72.07%-80.17%-73.59%-51.39%
Net Income-7.54M-13.37M-12.82M-22.17M-31.74M-36.40M-72.21M-36.64M
Net Income Margin-34.17%-74.41%-47.66%-52.53%-67.75%-72.47%-121.09%-65.20%
R&D9.53M8.99M8.23M13.07M17.53M21.90M25.50M13.80M
R&D as % of Total Revenue43.20%50.04%30.62%30.96%37.41%43.61%42.75%24.56%
Interest Expense1.15M1.53M976.00K486.00K129.00K201.00K0-
Interest Expense % of Total Revenue5.20%8.51%3.63%1.15%0.28%0.40%0.00%-

Balance Sheet

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets27.75M37.66M178.83M260.91M242.59M202.98M159.48M190.07M
Total Liabilities77.92M100.83M39.79M46.30M51.99M37.49M44.88M46.37M
Total Equity-50.18M-63.17M139.04M214.60M190.60M165.49M114.59M143.70M
Cash7.07M17.91M159.23M224.07M188.42M121.04M44.03M112.97M
Total Debt17.93M22.79M21.86M20.85M19.51M5.95M6.61M16.71M
Net Debt10.86M4.88M-137.37M-203.22M-168.91M-115.10M-37.42M-96.26M

Cash Flow

Currency: USD2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-8.90M-11.00M4.13M-29.08M-20.93M-25.06M-30.25M-23.69M
Investing Cash Flow-1.17M-392.00K-9.00K-737.00K-15.81M-26.40M-46.32M50.75M
Financing Cash Flow3.99M22.24M137.19M94.72M1.18M-15.94M-376.00K-697.00K
Capital Expenditure727.00K392.00K9.00K737.00K2.04M2.04M602.00K955.00K
Free Cash Flow-9.63M-11.40M4.12M-29.82M-22.98M-27.10M-30.85M-24.64M
Dividends Paid----262.00K---
FCF to OCF108.17%103.56%99.78%102.53%109.77%108.16%101.99%104.03%
Dividend Paid to FCF-----1.14%---

Earnings

Report DateMar 31, 2019Jun 30, 2019Sep 30, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 18, 2020Mar 30, 2021May 13, 2021Aug 4, 2021Nov 4, 2021Mar 7, 2022May 10, 2022Aug 9, 2022Nov 14, 2022Mar 7, 2023May 9, 2023Aug 8, 2023Nov 7, 2023Mar 5, 2024Apr 30, 2024Aug 6, 2024Nov 12, 2024Mar 3, 2025May 13, 2025Aug 5, 2025Nov 10, 2025Mar 3, 2026May 6, 2026Aug 11, 2026Nov 9, 2026
EPS Estimate0.000.000.000.000.000.00-0.10-0.16-0.22-0.21-0.14-0.18-0.30-0.26-0.21-0.26-0.35-0.34-0.29-0.26-0.36-0.34-0.29-0.35-0.27-0.14-0.11-0.08-0.14-0.14-0.16
EPS Actual-0.50-0.51-0.59-0.060.26-0.21-0.03-1.48-0.22-0.27-0.19-0.12-0.30-0.26-0.20-0.31-0.39-0.29-0.22-0.23-0.33-0.31-0.31-0.28-0.19-0.26-0.040.10-0.07-0.11-
Surprise------70.00%-825.00%0.00%-28.57%-35.71%33.33%0.00%0.00%4.76%-19.23%-11.43%14.71%24.14%11.54%8.33%8.82%-6.90%19.15%29.63%-85.71%63.64%225.00%50.00%21.43%-
Timing------After-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-

Key Statistics & Ratios

Market Cap472.86M
Enterprise Value355.37M
Trailing P/E0.00
Forward P/E0.00
Price / Sales7.77
Price / Book3.57
EPS-0.93
Book Value3.59
Revenue (TTM)60.84M
Gross Profit (TTM)32.03M
EBITDA-16.49M
Profit Margin-56.96%
Operating Margin-39.61%
Return on Equity-24.95%
Return on Assets-6.81%
Shares Outstanding41.33M
Shares Float28.06M
Beta0.68
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 4 analystsTarget 13.38
  • Strong Buy
    3
  • Hold
    1

Ownership Breakdown

Institutions
83.85%
Insiders
7.39%
Retail / Other
8.76%

Top Institutional Holders

  • First Light Asset Management, LLC
    6.28M15.20%
  • Awm Investment Company Inc
    5.20M12.58%
  • ARK Investment Management LLC
    1.95M4.71%
  • Arnhold & S. Bleichroeder Advisers, LLC
    1.86M4.50%
  • BlackRock Inc
    1.77M4.28%
  • Needham Investment Management, LLC
    1.24M3.00%
  • Vanguard Capital Management, LLC
    1.12M2.71%
  • Geode Capital Management, LLC
    695.46K1.68%
  • Granahan Investment Management Inc..
    695.07K1.68%
  • State Street Corp
    625.89K1.51%
  • Essex Investment Management Company, LLC
    470.24K1.14%
  • Morgan Stanley - Brokerage Accounts
    373.26K0.90%
  • Meros Investment Management, LP
    361.74K0.88%
  • Prescott Group Capital Management LLC
    361.60K0.87%

Top Fund Holders

  • ARK Genomic Revolution ETF
    2.02M4.88%
  • Needham Aggressive Growth Retail
    1.40M3.38%
  • Vanguard MStar Total Stk Mkt Idx Invest
    919.83K2.23%
  • First Eagle Small Cap Opportunity I
    853.78K2.07%
  • iShares Russell 2000 ETF
    745.87K1.80%
  • Avantis US Small Cap Value ETF
    730.58K1.77%